Delivery Order SPE2DB25D3306-SPE2DB26FUALN
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,207.19 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units under a firm fixed-price contract with an ultimate completion date of September 23, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract by the Defense Logistics Agency (DLA) to provide Pimecrolimus 1% Cream in 30-gram units. The $1,909.86 firm fixed price contract has a completion date of March 8, 2024. This award is not part of a set-aside program. Amerisourcebergen Drug Corp is the prime contractor and sole awardee on this contract, which is issued as a delivery order under the company's existing...
- This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract provides for the delivery of PIMECROLIMUS 1% CREAM 60GM, a pharmaceutical product, with a potential value of $1,378.27 and a completion date of March 8, 2024. This award is not associated with any set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,925.08 firm fixed-price contract is for the supply of Pimecrolimus 1% cream, a prescription topical medication. The award has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, to provide a broad range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,685.48 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30 gm, a pharmaceutical product. The contract has a completion date of February 7, 2022 and was awarded on February 4, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pimecrolimus cream. The $1,724.04 contract has a completion date of February 16, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,545.88 firm fixed price delivery order is for the provision of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUALNDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) for Pimecrolimus 1% Cream in a 30-gram size with a ceiling value of $1,404.72. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 16, 2025, and was awarded on October 15, 2025. No set-aside designation was applied to this award, indicating it was competitively awarded among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC serves as a flexible procurement mechanism enabling the company to supply pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's significant role as a pharmaceutical prime vendor demonstrates its capability to meet federal medical procurement requirements across multiple therapeutic domains and serve various government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/15/25 |